Treatment

Latest

CAR T-Cells Beat Non-Hodgkin's Lymphoma

Emily Dumler had 6 months to live after unsuccessful treatment for non-Hodgkin’s lymphoma, but has been in remission for three years since receiving CAR T-cell therapy.

By Katherine Malmo

What Is Follicular Lymphoma?

Follicular lymphoma is a slow-growing cancer which is not curable but instead is considered a long-term, chronic disease.

By Eileen Bailey

What Is Diffuse Large B-Cell Lymphoma?

Diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma, is aggressive, but up to three-quarters of patients are responsive to treatment.

By Eileen Bailey

Lymphoma Can Raise Your Heart Failure Risk

Having lymphoma or breast cancer was linked to a three-times higher risk of developing heart failure within five years of initial diagnosis.

By Amy Hendel, P.A.

'Robocop' CAR T Immune Cells Battle Lymphoma

Hear from a doctor on the front lines of research into CAR T-cell therapy, a promising new immunotherapy for treatment-resistant non-Hodgkin’s lymphoma.

By Rachel Zohn

Non-Hodgkin’s Lymphoma Survivor Side Effects

Chemotherapy and radiation can successfully treat non-Hodgkin’s lymphoma, but they can cause side effects that last or emerge years after treatment.

By Elizabeth Millard

Understanding Non-Hodgkin's Lymphoma Treatment

What's the key to successful treatment of non-Hodgkin's lymphoma? Understanding your diagnosis and treatment options, according to Dr. Gwen Nichols of the Leukemia & Lymphoma Society. She shares how best to navigate your path forward.

CAR T Cell Therapy Treatment for Non-Hodgkins Lymphoma

CAR T cell therapy is a new FDA approved immunotherapy for treating non-Hodgkin's lymphoma. Dr. Gwen Nichols explains CAR T's applications, process, and history as a cancer therapy.

Finding the Right Oncologist for Non-Hodgkin's Lymphoma

Dr. Gwen Nichols advises patients on key factors to look for in their health care team while navigating a non-Hodgkin's lymphoma diagnosis and treatment.

Advances in Non-Hodgkin's Lymphoma Therapies

Dr. Gwen Nichols, chief medical officer of the Leukemia & Lymphoma Society discusses major developments and what the future holds for non-Hodgkin's lymphoma treatment.